A detailed history of Marshall Wace, LLP transactions in Certara, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 43,000 shares of CERT stock, worth $452,790. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,000
Holding current value
$452,790
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.46 - $16.58 $449,780 - $712,939
43,000 New
43,000 $503,000
Q4 2023

Feb 14, 2024

SELL
$12.12 - $18.19 $5.08 Million - $7.62 Million
-418,889 Reduced 90.64%
43,238 $760,000
Q3 2023

Nov 14, 2023

BUY
$13.9 - $19.58 $6.42 Million - $9.05 Million
462,127 New
462,127 $6.72 Million
Q4 2022

Feb 14, 2023

SELL
$10.7 - $17.84 $3.77 Million - $6.29 Million
-352,438 Reduced 55.43%
283,407 $4.55 Million
Q3 2022

Nov 14, 2022

BUY
$12.84 - $24.13 $8.16 Million - $15.3 Million
635,845 New
635,845 $8.45 Million

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.68B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.